Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH): Clinical Trial Application for Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) Accepted

Stock News12-17

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotech Co., Ltd., has received the "Acceptance Notice" from the National Medical Products Administration (NMPA). The clinical trial application for the "Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)" submitted by the company has been accepted.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170612385?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 16:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170612385","market":"us","top_or_hot":-1,"title":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH): Clinical Trial Application for Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) Accepted","media":"Stock News","content":"<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotech Co., Ltd., has received the \"Acceptance Notice\" from the National Medical Products Administration (NMPA). The clinical trial application for the \"Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)\" submitted by the company has been accepted.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH): Clinical Trial Application for Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) Accepted</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH): Clinical Trial Application for Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) Accepted\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-17 16:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotech Co., Ltd., has received the \"Acceptance Notice\" from the National Medical Products Administration (NMPA). The clinical trial application for the \"Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)\" submitted by the company has been accepted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159646","symbol_name":"疫苗","start_time":0,"source_url":"","article_id":"1170612385","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170612385","pubTimestamp":1765960026,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotech Co., Ltd., has received the \"Acceptance Notice\" from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159646":"疫苗","603392":"万泰生物","09633":"农夫山泉","BK1200":"软饮料","LU1981816686.USD":"EASTSPRING INV ASIAN MULTI FACTOR EQUITY \"A\" (USD) ACC","BK0239":"医药制造","BK1589":"北水核心资产"},"translate_title":"北京万泰生物医药企业有限公司。(603392.SH)：重组呼吸道合胞病毒疫苗（CHO细胞）临床试验申请获受理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1,"603392":1,"09633":1},"content_text":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Xiamen Wantai Canghai Biotech Co., Ltd., has received the \"Acceptance Notice\" from the National Medical Products Administration (NMPA). The clinical trial application for the \"Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)\" submitted by the company has been accepted.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170612385","isCrawlerRequest":true}